Display options
Cite
Karunanithi S, Kumar G, Sharma P, et al. Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy. Indian J Nucl Med. 2015;30(1):31-8doi: 10.4103/0972-3919.147532.
Karunanithi, S., Kumar, G., Sharma, P., Bal, C., & Kumar, R. (2015). Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 30(1), 31-8. https://doi.org/10.4103/0972-3919.147532
Karunanithi, Sellam, et al. "Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy." Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India vol. 30,1 (2015): 31-8. doi: https://doi.org/10.4103/0972-3919.147532
Karunanithi S, Kumar G, Sharma P, Bal C, Kumar R. Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy. Indian J Nucl Med. 2015 Jan-Mar;30(1):31-8. doi: 10.4103/0972-3919.147532. PMID: 25589803; PMCID: PMC4290063.
Copy Download .nbib Format: NLM
Share it on

Indian J Nucl Med. 2015 Jan-Mar;30(1):31-8. doi: 10.4103/0972-3919.147532.

Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Sellam Karunanithi, Ganesh Kumar, Punit Sharma, Chandrasekhar Bal, Rakesh Kumar

Affiliations

  1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

PMID: 25589803 PMCID: PMC4290063 DOI: 10.4103/0972-3919.147532

Abstract

Generalized lymphadenopathy is a common and often vexing clinical problem caused by various inflammatory, infective and malignant diseases. We aimed to review briefly and highlight the potential role of (18)F-2-fluoro-2-deoxy-glucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) in such patients. (18)F-FDG PET/CT can play an important role in the management of generalized lymphadenopathy. It can help in making an etiological diagnosis; can detect extranodal sites of involvement and employed for monitoring response to therapy.

Keywords: 18F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography; generalized lymphadenopathy; lymphoma; sarcoidosis; tuberculosis

References

  1. Clin Nucl Med. 2014 Mar;39(3):268-9 - PubMed
  2. Curr Infect Dis Rep. 2001 Jun;3(3):233-241 - PubMed
  3. Nephrourol Mon. 2012 Spring;4(2):482-4 - PubMed
  4. Br J Haematol. 2010 Mar;148(5):673-89 - PubMed
  5. Diagn Interv Radiol. 2014 Mar-Apr;20(2):185-92 - PubMed
  6. J Clin Oncol. 1995 Jul;13(7):1726-33 - PubMed
  7. Arch Pathol Lab Med. 2000 Oct;124(10):1502-5 - PubMed
  8. Ann N Y Acad Sci. 2011 Jun;1228:46-58 - PubMed
  9. Mol Imaging Biol. 2009 Jul-Aug;11(4):224-8 - PubMed
  10. Br J Haematol. 2014 Feb;164(3):315-28 - PubMed
  11. Pediatr Infect Dis J. 2008 Feb;27(2):165-9 - PubMed
  12. Am Surg. 2007 Mar;73(3):294-5 - PubMed
  13. Rev Soc Bras Med Trop. 2011 Jan-Feb;44(1):26-9 - PubMed
  14. J Nucl Med. 2010 Jan;51(1):25-30 - PubMed
  15. N Engl J Med. 1975 Jan 2;292(1):1-8 - PubMed
  16. Clin Nucl Med. 2011 Apr;36(4):e13-5 - PubMed
  17. AJR Am J Roentgenol. 1982 Nov;139(5):1007-9 - PubMed
  18. Semin Nucl Med. 2013 Sep;43(5):349-66 - PubMed
  19. Clin Nucl Med. 2011 Apr;36(4):309-10 - PubMed
  20. Leuk Lymphoma. 2014 Sep;55(9):2079-84 - PubMed
  21. Rinsho Byori. 2012 Jun;60(6):560-4 - PubMed
  22. Clin Nucl Med. 2014 Feb;39(2):e146-59 - PubMed
  23. Clin Nucl Med. 2013 Jan;38(1):e50-2 - PubMed
  24. Br J Radiol. 2007 Jan;80(949):e24-6 - PubMed
  25. Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):142-4 - PubMed
  26. Insights Imaging. 2013 Apr;4(2):245-52 - PubMed
  27. Leuk Lymphoma. 2011 Aug;52(8):1517-22 - PubMed
  28. J Clin Invest. 2012 Oct;122(10):3439-47 - PubMed
  29. Zhonghua Xue Ye Xue Za Zhi. 2012 Jan;33(1):16-9 - PubMed
  30. Eur J Pediatr Surg. 2003 Oct;13(5):350-4 - PubMed
  31. Leuk Lymphoma. 2013 Oct;54(10):2163-7 - PubMed
  32. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):648-52 - PubMed
  33. J Nucl Med. 2009 May;50 Suppl 1:21S-30S - PubMed
  34. Clin Nucl Med. 2009 Dec;34(12):946-7 - PubMed
  35. Eur J Cancer. 2011 Jun;47(9):1312-8 - PubMed
  36. Ann Nucl Med. 2008 May;22(4):245-50 - PubMed
  37. Indian J Orthop. 2013 Nov;47(6):639-42 - PubMed
  38. Cancer. 2007 Jan 15;109 (2):292-9 - PubMed
  39. Melanoma Res. 2013 Aug;23 (4):336-9 - PubMed
  40. J Bras Pneumol. 2009 Nov;35(11):1145-51 - PubMed
  41. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):632-9 - PubMed
  42. European J Clin Med Oncol. 2010 Feb;2(1):131-138 - PubMed
  43. Oncologist. 2004;9(4):406-16 - PubMed
  44. Ann Oncol. 2004 Oct;15(10):1467-75 - PubMed
  45. Semin Diagn Pathol. 1990 Feb;7(1):19-73 - PubMed
  46. Chest. 2002 Apr;121(4):1177-82 - PubMed
  47. Am J Hematol. 2013 Oct;88(10):910-8 - PubMed
  48. Skeletal Radiol. 2012 Jun;41(6):715-7 - PubMed
  49. Blood. 2013 Jul 4;122(1):61-7 - PubMed
  50. Clin Nucl Med. 2013 May;38(5):339-42 - PubMed
  51. Lung Cancer. 2002 Jun;36(3):297-301 - PubMed
  52. Korean J Hematol. 2012 Sep;47(3):163-77 - PubMed

Publication Types